TGFβ1 and Treg cells: alliance for tolerance

Trends in Molecular Medicine

Volumn 13, Issue 11, 2007, Pages 492-501

  Bommireddy, Ramireddy ^a,b   Doetschman, Thomas ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 17; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

AUTOIMMUNE DISEASE; CAENORHABDITIS ELEGANS; CARCINOGENESIS; CELL ACTIVATION; CELL FUNCTION; CELL LINE; DROSOPHILA; NONHUMAN; PLEIOTROPY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CAENORHABDITIS ELEGANS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36048956108     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.08.005     Document Type: Review

References (96)

1. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
2. Bommireddy R., and Doetschman T. TGFβ, T-cell tolerance and anti-CD3 therapy. Trends Mol. Med. 10 (2004) 3-9
3. + regulatory T cell function. Eur. J. Immunol. 34 (2004) 2996-3005
4. Shevach E.M. Regulatory/suppressor T cells in health and disease. Arthritis Rheum. 50 (2004) 2721-2724
5. Rudensky A. Foxp3 and dominant tolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 (2005) 1645-1646
6. Annacker O., et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202 (2005) 1051-1061
7. Beissert S., et al. Regulatory T cells. J. Invest. Dermatol. 126 (2006) 15-24
8. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 177 (2006) 2331-2339
9. Izcue A., et al. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212 (2006) 256-271
10. Graca L., et al. Dominant transplantation tolerance. Curr. Opin. Immunol. 15 (2003) 499-506
11. + T cells during cure of colitis. J. Immunol. 177 (2006) 5852-5860
12. Li M.O., et al. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24 (2006) 99-146
13. Schmidt-Weber C.B., and Blaser K. Regulation and role of transforming growth factor-β in immune tolerance induction and inflammation. Curr. Opin. Immunol. 16 (2004) 709-716
14. Marie J.C., et al. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25 (2006) 441-454
15. Li M.O., et al. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
16. Rubtsov Y.P., and Rudensky A.Y. TGFβ signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7 (2007) 443-453
17. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
18. Korn T., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
19. Weaver C.T., et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
20. Chen W., and Wahl S.M. TGFβ: receptors, signaling pathways and autoimmunity. Curr. Dir. Autoimmun. 5 (2002) 62-91
21. 2+-calcineurin-mediated activation in thymocytes. J. Immunol. 170 (2003) 3645-3652
22. Bommireddy R., et al. TGFβ1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 170 (2003) 4612-4622
23. Shou W., et al. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391 (1998) 489-492
24. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172 (2004) 5149-5153
25. + regulatory cells. J. Immunol. 176 (2006) 3321-3329
26. Veldhoen M., et al. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7 (2006) 1151-1156
27. Ivanov I.I., et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17(+) T helper cells. Cell 126 (2006) 1121-1133
28. + T cells at priming and at recall: differential involvement of Stat4 and T-bet. J. Immunol. 174 (2005) 5950-5958
29. + T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J. Immunol. 175 (2005) 5666-5674
30. Gorelik L., et al. Cutting edge: TGFβ inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165 (2000) 4773-4777
31. + lymphocytes. J. Immunol. 171 (2003) 5328-5336
32. Zhou M., and Ouyang W. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol. Res. 28 (2003) 25-37
33. Bommireddy R., et al. Self-antigen recognition by TGFβ1-deficient T cells causes their activation and systemic inflammation. Lab. Invest. 86 (2006) 1008-1019
34. Mangan P.R., et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
35. Gorham J.D., et al. Genetic regulation of autoimmune disease: BALB/c background TGFβ1-deficient mice develop necroinflammatory IFN-γ-dependent hepatitis. J. Immunol. 166 (2001) 6413-6422
36. Bommireddy R., et al. Elimination of both CD4(+) and CD8(+) T cells but not B cells eliminates inflammation and prolongs the survival of TGFβ1-deficient mice. Cell. Immunol. 232 (2004) 96-104
37. Manzotti C.N., et al. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Eur. J. Immunol. 36 (2006) 1413-1422
38. + regulatory T cells independent of autocrine TGFβ1. Blood 103 (2004) 4594-4601
39. Fahlen L., et al. T cells that cannot respond to TGFβ escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201 (2005) 737-746
40. Nakamura K., et al. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194 (2001) 629-644
41. Piccirillo C.A., et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196 (2002) 237-246
42. Li M.O., et al. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26 (2007) 579-591
43. Kullberg M.C., et al. TGFβ1 production by CD4(+)CD25(+) regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35 (2005) 2886-2895
44. + regulatory T cells. J. Exp. Med. 201 (2005) 1061-1067
45. Gregg R.K., et al. A sudden decline in active membrane-bound TGF{beta} impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol. 173 (2004) 7308-7316
46. Carrier Y., et al. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGFβ T cell-transgenic mice. J. Immunol. 178 (2007) 179-185
47. Graca L., et al. Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells. Trends Immunol. 26 (2005) 130-135
48. - cells to develop suppressive activity: the role of IL-2, TGFβ, and IL-10. J. Immunol. 172 (2004) 5213-5221
49. Chatenoud L. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications. Curr. Opin. Immunol. 17 (2005) 632-637
50. + regulatory T cells during autoimmune diabetes. J. Exp. Med. 201 (2005) 1333-1346
51. + T regulatory cells control anti-islet CD8+ T cells through TGF{beta}-TGF{beta} receptor interactions in Type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10878-10883
52. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16 (2004) 1241-1249
53. Tang Q., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006) 83-92
54. Edinger M., et al. CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9 (2003) 1144-1150
55. Kane L.P., et al. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12 (2000) 242-249
56. Grewal I.S., et al. Expression of transgene encoded TGFβ in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J. Autoimmun. 19 (2002) 9-22
57. Ruiz P.A., et al. IL-10 gene-deficient mice lack TGFβ/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol. 174 (2005) 2990-2999
58. + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
59. Gambineri E., et al. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15 (2003) 430-435
60. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8 (2007) 277-284
61. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226
62. Wu Y., et al. FOXP3 Controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
63. 2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197 (2003) 1689-1699
64. Ono M., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
65. Bell M.P., et al. Forkhead Box P3 regulates TLR10 expression in human T regulatory cells. J. Immunol. 179 (2007) 1893-1900
66. - T cells by T cell receptor stimulation is TGF{beta}-dependent but does not confer a regulatory phenotype. Blood 110 (2007) 2983-2990
67. Sansom D.M., and Walker L.S. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212 (2006) 131-148
68. Chen W., et al. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGFβ) production by murine CD4(+) T cells. J. Exp. Med. 188 (1998) 1849-1857
69. Macian F., et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109 (2002) 719-731
70. Wohlfert E.A., et al. Cutting edge: Deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGFβ sensitivity in vitro and in vivo. J. Immunol. 176 (2006) 1316-1320
71. -/- mice. J. Immunol. 173 (2004) 1059-1065
72. Graca L., et al. Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165 (2000) 4783-4786
73. Ochi H., et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4(+)CD25(-)LAP(+) T cells. Nat. Med. 12 (2006) 627-635
74. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
75. + regulatory T-cell-mediated suppression. Immunology 118 (2006) 240-249
76. Hryniewicz A., et al. CTLA-4 blockade decreases TGFβ, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 108 (2006) 3834-3842
77. + dendritic cells. J. Immunol. 174 (2005) 2061-2070
78. Grohmann U., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3 (2002) 1097-1101
79. Munn D.H., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22 (2005) 633-642
80. Mellor A.L., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171 (2003) 1652-1655
81. Tivol E.A., et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158 (1997) 5091-5094
82. + regulatory T cells via a TGF{beta}- and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
83. Mucida D., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007) 256-260
84. Acosta-Rodriguez E.V., et al. Interleukins 1beta and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 (2007) 942-949
85. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
86. Shull M.M., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
87. Engle S.J., et al. Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 59 (1999) 3379-3386
88. Letterio J.J., et al. Autoimmunity associated with TGFβ1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98 (1996) 2109-2119
89. Kobayashi S., et al. Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGFβ1 null mouse. J. Immunol. 163 (1999) 4013-4019
90. Gorelik L., and Flavell R.A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181
91. Lucas P.J., et al. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J. Exp. Med. 191 (2000) 1187-1196
92. Tivol E.A., et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (1995) 541-547
93. Yang X., et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGFβ. EMBO J. 18 (1999) 1280-1291
94. Kim B.G., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441 (2006) 1015-1019
95. Chiang Y.J., et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403 (2000) 216-220
96. Lorenz U., et al. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9624-9629